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Functional Melanocytes Are Readily Reprogrammable
from Multilineage-Differentiating Stress-Enduring
(Muse) Cells, Distinct Stem Cells in Human Fibroblasts
Kenichiro Tsuchiyama1,2, Shohei Wakao2, Yasumasa Kuroda3, Fumitaka Ogura2, Makoto Nojima2,
Natsue Sawaya1, Kenshi Yamasaki1, Setsuya Aiba1 and Mari Dezawa2,3
The induction of melanocytes from easily accessible stem cells has attracted attention for the treatment of
melanocyte dysfunctions. We found that multilineage-differentiating stress-enduring (Muse) cells, a distinct stem
cell type among human dermal fibroblasts, can be readily reprogrammed into functional melanocytes, whereas
the remainder of the fibroblasts do not contribute to melanocyte differentiation. Muse cells can be isolated as
cells positive for stage-specific embryonic antigen-3, a marker for undifferentiated human embryonic stem cells,
and differentiate into cells representative of all three germ layers from a single cell, while also being
nontumorigenic. The use of certain combinations of factors induces Muse cells to express melanocyte
markers such as tyrosinase and microphthalmia-associated transcription factor and to show positivity for the
3,4-dihydroxy-L-phenylalanine reaction. When Muse cell–derived melanocytes were incorporated into three-
dimensional (3D) cultured skin models, they localized themselves in the basal layer of the epidermis and
produced melanin in the same manner as authentic melanocytes. They also maintained their melanin production
even after the 3D cultured skin was transplanted to immunodeficient mice. This technique may be applicable to
the efficient production of melanocytes from accessible human fibroblasts by using Muse cells, thereby
contributing to autologous transplantation for melanocyte dysfunctions, such as vitiligo.
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INTRODUCTION
Melanocytes produce melanin and deliver them to neighbor-
ing keratinocytes to protect the skin from UV rays (Slominski
et al., 2004; Kondo et al., 2011). Melanocyte dysfunction
results in a variety of pigment disorders, such as albinism and
vitiligo, which cause not only cosmetic problems but also
increase the risk of skin cancers due to incomplete protection
from UV rays (Mabula et al., 2012).
Current treatments for vitiligo include topical treatment with
corticosteroids or immunomodulators, UV treatment, and
autologous skin grafts (Alikhan et al., 2011; Felsten et al.,
2011). The effectiveness of these treatments, however, is
inadequate. Autologous cultured melanocyte transplantation
is a potential cell therapy (van Geel et al., 2001; Fioramonti
et al., 2012), but it is not widely used because human adult
melanocytes are difficult to culture and amplify large
scale in vitro. Several groups recently reported successful
melanocyte induction from embryonic stem (ES) or induced
pluripotent stem (iPS) cells (Yamane et al., 1999; Fang et al.,
2006; Motohashi et al., 2006; Nissan et al., 2011; Ohta et al.,
2011; Yang et al., 2011). Indeed, these are attractive cell
sources for melanocyte induction, but the ethical problems in
obtaining ES cells (Knoppers et al., 2009; Manzar et al., 2011)
and the risk of tumorigenesis for both ES and iPS cells are
obstacles to clinical use (Okita et al., 2007; Fong et al., 2010;
Ben-David, 2011; Goldring et al., 2011).
Mesenchymal stem cells (MSCs) are adult stem cells with a
lower risk of tumorigenesis that exist in mesenchymal tissues,
such as the bone marrow, dermis, fat tissue, and dental pulp,
and are used for the treatment of many kinds of diseases
(Macchiarini et al., 2008; Hare et al., 2009; Jiang et al., 2011;
Sng et al., 2012). MSCs have attracted attention because of
their ability to differentiate into a broad spectrum of cells.
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MSCs can differentiate not only into mesodermal lineage
cells but also into ectodermal or endodermal lineage cells
(Pittenger et al., 1999; Dezawa et al., 2004; Sakaida et al.,
2004; Phinney et al., 2007). Melanocytes have also been
induced from dental pulp stem cells (DPSCs) (Stevens et al.,
2008; Paino et al., 2010) However, MSCs generally comprise
crude cell populations and contain different cell types on the
basis of their cell surface antigens because they are usually
harvested just as adherent cells from mesenchymal tissues.
Therefore, the cells responsible for differentiation across the
oligolineage boundaries between the mesoderm and the
ectoderm, namely mesenchymal to melanocytes, remain
unknown.
We recently reported a type of stem cell that exists
among adult human MSCs that we named multilineage-
differentiating stress-enduring cells (Muse cells) (Kuroda
et al., 2010; Wakao et al., 2011). Muse cells normally exist
in human mesenchymal cultured cells, such as dermal
fibroblasts and bone marrow stromal cells, and also in
mesenchymal tissue, such as dermis and bone marrow.
Muse cells have characteristics similar to both pluripotent
stem cells and MSCs: they can be isolated by FACS as cells
double positive for pluripotency (stage-specific embryonic
antigen-3 (SSEA-3), a marker for undifferentiated human ES
cells) and mesenchymal markers (CD105) and have the ability
to self-renew and differentiate into endodermal-, mesodermal-,
and ectodermal-lineage cells from a single cell. Unlike other
pluripotent stem cells such as ES cells and iPS cells, however,
Muse cells have low telomerase activity and do not form
tumors in vivo. Thus, they have a high potential for clinical
application. Recently, skin-derived precursor (SKPs) cells have
been reported as multipotent MSCs in human foreskins (Toma
et al., 2005). However, unlike SKPs, Muse cells are located
sparsely in the connective tissue of the dermis and the adipose
tissue and are not associated with any particular structure such
as dermal papilla, connective tissue sheath, or hair follicular
epithelium. In addition, Muse cells do not express the SKP
markers Snail and Slug (Wakao et al., 2011). These data
indicate that Muse cells are distinct from SKPs.
We recently discovered that Muse cells in human dermal
fibroblasts are readily reprogrammed into functional melano-
cytes by using certain combinations of factors and cytokines.
Muse cell–derived melanocytes (Muse melanocytes) expressed
melanocyte markers such as microphthalmia-associated
transcription factor (MITF), tyrosinase-related protein 1 (TRP-1),
dopachrome tautomerase (DCT), KIT, gp100, and tyrosinase,
and were positive for the 3,4-dihydroxy-L-phenylalanine
(L-DOPA) reaction assay, produced melanin, and integrated
into the basal layer of epidermis. In contrast, when the Muse
cells were removed from human fibroblasts before melanocyte
induction, the remaining cells (namely, ‘‘non-Muse cells’’)
failed to become melanocytes and did not produce melanin.
This finding indicates that Muse cells, the cells that already
have triploblastic differentiation ability, can cross the oligoli-
neage boundary between the mesodermal and ectodermal
lineages and become reprogrammed into melanocytes,
whereas the remaining fibroblasts do not participate in this
event. Thus, Muse cells are an ideal cell source for generating
functional melanocytes from adult human fibroblasts
that can be applied to autologous transplantation for pigment
disorders.
RESULTS
Isolation of Muse cells from human fibroblasts
Muse cells were collected from normal human dermal
fibroblasts (NHDFs; Lonza Walkersville, MD). Because
100% of SSEA-3-positive cells from NHDF are positive for
CD105, as described previously (Kuroda et al., 2010), we
isolated Muse cells by FACS as SSEA-3-positive cells. The ratio
of SSEA-3-positive cells in NHDFs was in the range of 2 to 3%,
consistent with the previous reports (Figure 1a).
We evaluated the differentiation ability of the collected
Muse cells. When each Muse cell was cultured in a single-cell
suspension culture after limiting dilution, cell clusters very
similar to ES cell–derived embryoid bodies, namely Muse
cell–derived cell clusters (M-clusters), were generated by
day 7 (Figure 1b). These clusters were positive for alkaline
phosphatase staining (Figure 1c); they expressed pluripotency
markers such as Nanog, Oct 3/4, and Sox2; and they could
self-renew, as reported previously (data not shown) (Wakao
et al., 2011). To observe their differentiation ability, single
M-clusters were individually transferred onto gelatin-coated
dishes. After 7 days, spontaneous differentiation of the cells
expanding from the M-cluster into cells positive for
neurofilament (ectodermal marker), a-smooth muscle actin
(mesodermal marker), and GATA4 (endodermal marker) were
detected (Figures 1d-f). In contrast, non-Muse cells did not
form clusters in a single-cell suspension culture, and therefore
differentiation of non-Muse cells into endodermal-, mesoder-
mal-, and ectodermal-lineage cells could not be observed.
These results are consistent with our previous report (Wakao
et al., 2011).
Differentiation of Muse cells into melanocytes
NHDF was separated into Muse and non-Muse cells by FACS
and both were cultured separately in a specific differentiation
medium containing 10 factors: Wnt3a, stem cell factor (SCF),
endothelin-3 (ET-3), basic fibroblast growth factor, linoleic
acid, cholera toxin, L-ascorbic acid, 12-O-tetradecanoyl-
phorbol 13-acetate, insulin–transferrin–selenium, and dexa-
methasone (Figure 1g). The morphology of the Muse cells
began to change and cells with dendrites appeared within
3 weeks. Cell size was slightly reduced by 5 weeks, and by
6 weeks, the cells had morphology similar to that of human
melanocytes (Figure 2a and b). However, such changes did
not occur in non-Muse cells, and most of the non-Muse cell–
derived cells remained fibroblast-like cells, even after 6 weeks
of differentiation.
Characterization of Muse melanocytes
The expression of melanocyte-related markers was examined
in Muse melanocytes and non-Muse cell–derived cells after
6 weeks of differentiation. Human melanocytes were used as a
positive control. In reverse transcription–RT–PCR, cells
induced from Muse cells expressed MITF, KIT, TRP-1, and
gp100 at 3 weeks (Figure 3a). In addition, Muse cells
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expressed DCT at 5 weeks and tyrosinase at 6 weeks. We
previously reported that naive Muse cells do not express either
DCT or TRP-1 (Wakao et al., 2011); thus, the expression of
these melanocyte-related markers in Muse cells is thought to
be induced by differentiation. Although non-Muse cell–
derived cells expressed MITF, KIT, and TRP-1 after 3 weeks,
DCT, gp100, and tyrosinase were not expressed in these cells
even after 6 weeks of differentiation (Figure 3a).
During immunocytochemical analysis, cells positive for
tyrosinase, gp100, and MITF were detected in Muse melano-
cytes (6 weeks), as in the case of human melanocytes, whereas
none of the cells positive for these melanocyte markers were
observed in non-Muse cell–derived cells at the same time
point (Figure 3b). Although an MITF signal was detected in
non-Muse cell–derived cells in RT–PCR (Figure 3a), the
protein expression level was not high enough to be detected
by immunocytochemistry.
Muse melanocytes were further evaluated by the L-DOPA
reaction assay to examine melanin productivity. Many cells
were positive for the L-DOPA reaction assay (Figure 3c). These
results suggested that cells with characteristics similar to those
of human melanocytes were induced from Muse cells but not
from non-Muse cells.
Effect of factors on melanocyte differentiation
To investigate the factors essential for melanocyte induction
and to estimate whether the number of factors could be
reduced from 10, 7 combinations of factors were created
(Figure 4a). Muse cells cultured in media 1, 2, 3, 4, and 7
grew well, but they did not become similar to authentic
human melanocytes. Muse cells cultured in media 5 and 6 did
not proliferate well and all of them died within 20 days
(Figure 4a and c). RT–PCR analysis revealed no expression of
tyrosinase in all 7 sets of medium at 6 weeks, and thus these
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Figure 1. Characterization of Muse (multilineage-differentiating stress-enduring) cells. (a) FACS analysis for stage-specific embryonic antigen-3 (SSEA-3)
expression in naive normal human dermal fibroblasts (NHDFs). (b) M-cluster formed in single-cell suspension culture at day 7. (c) Alkaline phosphatase (ALP)
staining of an M-cluster. (d–f) Immunocytochemistry for (d) neurofilament, (e) a-smooth muscle actin (a-SMA), and (f) GATA4 in cells derived from a single
M-cluster. (g) Schematic diagram of melanocyte differentiation from Muse cells and non-Muse cells. Scale bars¼50mm (b–f). b-FGF, basic fibroblast growth factor;
ET-3, endothelin-3; ITS, insulin–transferrin–selenium; SCF, stem cell factor; TPA, 12-O-tetradecanoyl-phorbol 13-acetate.
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media were not superior to the medium with 10 factors in
melanocyte induction (Figure 4b). Muse cells cultured in
media 1 and 2 expressed only MITF and/or KIT. In media 3,
4, and 7, Muse cells expressed several melanocyte-related
markers but not tyrosinase.
Generation of 3D cultured skin using Muse melanocytes
We tried to construct a three-dimensional (3D) cultured skin
using Muse melanocytes, as well as other cell types. A gel
layer was created comprising collagen type 1 and NHDF to
mimic the dermis. For construction of the epidermis, either
culture 1, comprising keratinocytesþMuse melanocytes, or
culture 2, comprising keratinocytes only, or culture 3, com-
prising keratinocytesþhuman melanocytes, or culture 4,
comprising keratinocytesþnon–Muse cell-derived cells, was
seeded onto the gel layer. After 15 days, pigmented cells were
observed in the basal layer of the epidermis of cultures 1 and 3
(Figure 5a and b). Because culture 1 comprised human
keratinocytes and Muse melanocytes, and keratinocytes do
not normally produce melanin, the cells producing melanin in
culture 1 were considered to be Muse melanocytes
(Figure 5b). In addition, cells positive for MITF, tyrosinase,
TRP-1, gp100, and S100 were identified in both cultures 1
and 3, and the Fontana–Masson staining revealed the presence
of melanin in the epidermis of both cultures (Figure 5c). In
contrast, no pigmented cells or cells positive for melanocyte-
related markers and the Fontana–Masson staining were
observed in the cultured skin from cultures 2 and 4
(Figure 5a and c). The spontaneous differentiation potential
of Muse cells in the 3D cultured skin was also examined. We
mixed green fluorescent protein (GFP)–labeled undifferen-
tiated Muse cells (naive Muse cells) with keratinocytes to
construct the epidermis of the 3D cultured skin. After 15 days,
GFP-positive naive Muse cells were identified in the epidermis
but none of them expressed melanocyte markers S100, TRP-1,
or tyrosinase (Supplementary Figure S1 online). This result
indicated that naive Muse cells do not spontaneously differ-
entiate into melanocytes even if they are integrated into the
epidermal layer of 3D cultured skin.
As some groups reported that the 3D cultured human skin
model reflects the physiological situation of human melano-
cytes in human skin more accurately than the experiment
using mouse skin (Haake and Scott, 1991; Meier et al., 2000),
we used 3D cultured skin to evaluate the migration potential
of naive Muse cells and Muse melanocytes. GFP-positive
naive Muse cells or Muse melanocytes mixed with NHDF
were embedded into the dermal equivalent of 3D cultured
skins and then seeded human keratinocytes only on the top
of the dermal equivalent. After 15 days, GFP-labeled naive
Muse cells were detected in the epidermis of 3D cultured
skin (Supplementary Figure S2a online), although they did
not express S100, TRP-1, or tyrosinase, as stated above
(Supplementary Figure S1 online). Some of the Muse
melanocytes migrated from the dermal equivalent, integrated
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Figure 2. Morphology of Muse (multilineage-differentiating stress-enduring) cells and non-Muse cells after differentiation. (a) Microscopic images of Muse cells
and non-Muse cells before and 3, 5, and 6 weeks after the differentiation. Microscopic images of naive normal human dermal fibroblasts (NHDFs) and human
melanocytes are also provided. Scale bars¼ 100mm. (b) High magnification of Muse cells and non-Muse cells at 6 weeks after differentiation. Normal human
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into the epidermal layer, and expressed S100 and TRP-1
(Supplementary Figure S2b online), showing that Muse mel-
anocytes have the potential of migrating into the epidermis
where human melanocytes normally reside.
Functional evaluation of Muse melanocytes in vivo
To investigate whether Muse melanocytes can survive and
maintain their melanocyte functions for a certain period of
time in vivo, we transplanted 3D cultured skin containing
Muse melanocytes onto the back skin of severe combined
immunodeficient mice. The 3D cultured skin containing
human melanocytes and 3D cultured skin containing only
keratinocytes were transplanted as positive and negative
controls, respectively. At 10 days after transplantation of
the skin containing human melanocytes, some melanocytes
were histologically detected in the basal layer of the graft
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Figure 3. Characterization of Muse (multilineage-differentiating stress-enduring) melanocytes. (a) Reverse transcription–PCR (RT–PCR) analysis of
microphthalmia-associated transcription factor (MITF), KIT, tyrosinase-related protein 1 (TRP-1), dopachrome tautomerase (DCT), gp100, and tyrosinase at 3, 5,
and 6 weeks of differentiation in both Muse and non-Muse cells. The positive control was human melanocytes and the negative controls were naive normal human
dermal fibroblasts (NHDFs) and no-template. (b) Immunocytochemical analysis of the melanocyte markers MITF, gp100, and tyrosinase in Muse and non-Muse
cells at 6 weeks after differentiation. The positive control was human melanocytes and the negative control was naive Muse cells without primary antibody. Scale
bars¼ 50mm. (c) The 3,4-dihydroxy-L-phenylalanine (L-DOPA) reaction assay of Muse melanocytes (6 weeks), human melanocytes, and naive NHDFs. The
pigmented cells are L-DOPA-positive cells. Scale bars¼ 100mm.
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(Figure 6a and b). In the negative control, the skin graft did not
appear pigmented, and no pigmented cells were observed
histologically. Histologic evaluation revealed that skin grafts
with Muse melanocytes contained Muse melanocytes located
in the basal layer that were brown in color (Figure 6b), and
immunohistochemical analysis revealed that they were posi-
tive for MITF, tyrosinase, TRP-1, gp100, and S100, the same as
grafted human melanocytes (Figure 6c). Furthermore, Muse
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Figure 4. Effect of factors on melanocyte differentiation. (a) Summary of the proliferating capacity and melanocyte marker expression of Muse (multilineage-
differentiating stress-enduring) cells cultured in seven different media. (b) Reverse transcription–PCR (RT–PCR) for microphthalmia-associated transcription
factor (MITF), KIT, tyrosinase-related protein 1 (TRP-1), dopachrome tautomerase (DCT), gp100, and tyrosinase in Muse cells at 6 weeks of culture in five different
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melanocytes and the neighboring keratinocytes were positive
for Fontana–Masson staining, as seen in human melanocytes
(Figure 6c). Following transplantation of 3D cultured skin
containing GFP-labeled Muse melanocytes, GFP-positive
Muse melanocytes were confirmed to be located within the
grafted skin, demonstrating that these GFP-positive cells were
transplanted cells and not derived from the host (Figure 6d).
These findings indicated that Muse melanocytes homed to the
basal layer of the epidermis, produced melanin, and delivered
it to the neighboring keratinocytes in vivo. The negative
control, skin graft with keratinocytes only, was negative for
all melanocyte-related markers and for the Fontana–Masson
staining (Figure 6c).
We performed double staining for the melanocyte marker
S100 and the proliferative marker Ki-67 to investigate the
proliferation capacity of Muse melanocytes; 9.5% of Muse
melanocytes expressed both Ki-67 and S100 (Supplementary
Figure S3 online).
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Figure 5. Histologic analysis of three-dimensional (3D) cultured skin. (a) Hematoxylin and eosin (H&E) staining of 3D cultured skin containing human
melanocytes, Muse (multilineage-differentiating stress-enduring) melanocytes, non-Muse cells, and keratinocytes alone. (b) H&E staining of the 3D cultured skin
containing Muse melanocytes (arrowheads indicate Muse melanocytes). (c) Immunohistochemical analysis of microphthalmia-associated transcription factor
(MITF), tyrosinase, tyrosinase-related protein 1 (TRP-1), gp100, and S-100, and the Fontana–Masson staining of the 3D cultured skin. Scale bars¼50mm.
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Figure 6. Functional characterization of Muse (multilineage-differentiating stress-enduring) melanocytes after transplantation into the back skin of severe
combined immunodeficient (SCID) mouse. (a) Macroscopic observation of skin grafts containing Muse melanocytes, human melanocytes, and keratinocytes only
10 days after transplantation. (b) Hematoxylin and eosin staining of each skin graft. Scale bars¼100mm (upper panels) and 50mm (lower panels).
(c) Immunohistochemical analysis of microphthalmia-associated transcription factor (MITF), tyrosinase, tyrosinase-related protein 1 (TRP-1), gp100, S100, and the
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Alexa-568 (in red) was observed (arrow). Scale bars¼50mm. DAPI, 4’,6-diamidino-2-phenylindole.
K Tsuchiyama et al.
Melanocytes Are Inducible from Muse Cells
2432 Journal of Investigative Dermatology (2013), Volume 133
DISCUSSION
The findings of this study revealed that a specific type of stem
cell, Muse cells, among NHDF can be readily reprogrammed
to functional melanocytes by using a specific combination of
factors and cytokines, whereas other cells among NHDF, non-
Muse cells, cannot. Muse melanocytes expressed melanocyte
markers during immunocytochemical analysis and RT–PCR
showed a positive reaction to L-DOPA in vitro, could grow in
3D cultured skin, survived in vivo, expressed melanocyte
markers, and produced melanin after transplantation to the
back skin of severe combined immunodeficient mice. Thus,
Muse melanocytes are considered to be equivalent to
melanocytes.
DPSCs, a MSC type, are reported to differentiate into
melanocytes (Stevens et al., 2008; Paino et al., 2010).
Stevens et al. (2008) successfully induced cells that
expressed the melanocyte marker, Mart-1 (melanoma
antigen recognized by T-cells 1), from CD34( )/CD271(þ )
DPSCs. Although Muse cells in NHDF are also CD34( ), they
might be distinct from dental pulp cells because NHDF-
derived Muse cells are negative for CD271, as reported
previously. Whether or not Muse cells are contained in the
dental pulp mesenchymal cells is an interesting question that
should be examined in future studies. Paino et al. (2010)
reported that DPSCs spontaneously differentiate into
melanocytes without any stimulation. The spontaneously
differentiated cells express DCT, TRP-1, and Mart-1 and are
positive for the L-DOPA reaction assay. Although spontaneous
differentiation is indeed attractive, more than 150 days were
required. Compared with melanocytes derived from DPSCs,
Muse cells could differentiate into melanocytes within
6 weeks and expressed tyrosinase, the essential enzyme for
producing melanin. For these reasons, Muse melanocytes are
expected to be practical for clinical use.
Several groups have already reported that melanocytes can
be induced from ES cells and iPS cells (Yamane et al., 1999;
Fang et al., 2006; Motohashi et al., 2006; Nissan et al., 2011;
Ohta et al., 2011; Yang et al., 2011). These melanocytes, like
Muse melanocytes, express several melanocyte-related
markers containing tyrosinase and produce melanin in 3D
cultured skin. The techniques for inducing melanocytes from
Muse cells are important in relation to the clinical application.
ES cells and iPS cells increase the risk for tumorigenesis (Okita
et al., 2007; Fong et al., 2010; Ben-David et al., 2011;
Goldring et al., 2011), whereas MSCs, which contain Muse
cells, have a low risk of tumorigenesis and have already been
applied to patients in many clinical trials (Kuroda et al., 2011).
Because ES cells are obtained from fertilized eggs, treating ES
cells requires much more effort and poses more ethical
problems (Knoppers et al., 2009; Manzar et al., 2011). The
iPS cells are obtained from somatic cells such as fibroblasts,
and hence the ethical problems are avoided, but they require
artificial gene transduction to generate pluripotent stem cells
(Takahashi et al., 2006, 2007). Muse cells, in contrast,
normally reside in accessible mesenchymal tissue such as
the dermis and in commercially available fibroblasts, and
hence that they are an attractive cell source for clinical and
industrial uses. In addition, Muse cells are easily isolated from
mesenchymal cells by simple labeling with SSEA-3 in a cell-
sorting system, and this is beneficial particularly for industrial
use. As Muse cells can be obtained from accessible
mesenchymal tissues, autologous transplantation of Muse
melanocytes can also be expected.
Human melanocyte stem cells are known to reside in hair
follicles, have self-renewal capacity, and have a role in
maintaining the number of melanocytes in the epidermis.
Both DCT and PAX3 are known as markers of melanocyte
stem cells. We have demonstrated DCT expression of Muse
melanocytes at the mRNA level. In order to investigate the
proliferative capacity of Muse melanocytes, we examined the
Ki-67 expression of Muse melanocytes (Supplementary Figure
S3 online). The result showed that 9.5% of Muse melanocytes
expressed Ki-67. In addition, these Ki-67-positive cells were
also positive for S-100, a marker for melanocytes. Although
in-depth analysis is needed to confirm the self-renewal ability of
Muse cells, these results indirectly suggested the self-renewal
capacity of Muse melanocytes after transplantation.
The Wnt3a, ET-3, SCF, basic fibroblast growth factor, and
cAMP inducers (cholera toxin and 12-O-tetradecanoyl-
phorbol 13-acetate) used in the differentiation medium are
known to promote the expression of transcription factors
PAX3, SOX10, CREB, and LEF1 through intracellular signaling
(Steingrimsson et al., 2004; Kondo et al., 2011; Dong et al.,
2012). These four transcription factors regulate the promoter
of MITF-M, which is one of the MITF variants specific
for melanocytes and has a crucial role in melanocyte
differentiation, proliferation, survival, and melanogenesis. In
view of this, Wnt3a, ET-3, SCF, basic fibroblast growth factor,
and cAMP inducers in the differentiation medium are
considered to induce melanocyte-related factors in Muse
cells through MITF-M activation. Ascorbic acid is known to
stimulate the activity and synthesis of tyrosinase (Lee SA et al.,
2011). Dexamethasone was recently reported to promote the
generation of melanocytic cells from mouse ES cells (Yamane
et al., 1999). Both linoleic acid and insulin–transferrin–
selenium supplement were used as supplemental factors in
low serum medium. Collectively, it is supposed that these
factors cooperatively worked on the efficient induction of
Muse cells into melanocytes. To investigate the essential
factors for melanocyte reprogramming, we created seven
combinations of factors based on articles reporting melano-
cyte induction from various stem cells (Yamane et al., 1999;
Motohashi et al., 2007; Paino et al., 2010). Fang et al. (2006)
described that a combination of three factors (Wnt3a, ET-3,
and SCF) is sufficient to induce melanocytes from pluripotent
stem cells. In our experiment, when Muse cells were cultured
in medium lacking any of those three factors, they expressed
very few melanocyte-related markers and their morphology
was different from that of authentic melanocytes. In addition,
Muse cells cultured in medium containing only those three
factors expressed MITF, KIT, TRP-1, DCT, and gp100, but not
tyrosinase, suggesting that although these three factors are
necessary for differentiation into melanocytes, Muse cells
need additional differentiation-enhancing factors such as
cholera toxin, 12-O-tetradecanoyl-phorbol 13-acetate, and
linoleic acid in order to become mature melanocytes.
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MATERIALS AND METHODS
Melanocyte induction
After sorting, Muse cells and non-Muse cells were seeded separately
at a density of 10,000 cells per six-well plate and cultured for 1 day in
a-MEM (Invitrogen, Carlsbad, CA). The cells were then cultured in
differentiation medium containing 0.05 M dexamethasone (Sigma-
Aldrich, St Louis, MO), 1 insulin–transferrin–selenium (Invitrogen),
1 mg ml 1 linoleic acid–BSA (Sigma-Aldrich), 30% low-glucose
DMEM (Invitrogen), 20% MCDB-201 medium (Sigma-Aldrich),
10 4 M L-ascorbic acid (Sigma-Aldrich), 50% DMEM conditioned
by L-Wnt3a cells (ATCC, Manassas, VA), 50 ng ml 1 SCF (R&D
Systems, Minneapolis, MN), 10 nM ET-3 (Sigma-Aldrich), 20 pM
cholera toxin (Wako, Osaka, Japan), 50 nM 12-O-tetradecanoyl-
phorbol 13-acetate (Sigma-Aldrich), and 4 ng ml 1 basic fibroblast
growth factor (Wako). All chemical reagents were treated according
to the product information sheets. Cells were maintained in this
differentiation medium for 6 weeks. The medium was changed every
2 days. Cultures were passaged when cells reached 50 to 80%
confluency. Melanocyte induction from both Muse and non-Muse
cells was repeated at least three times.
The methods for cell culture, FACS, evaluation of Muse cell
pluripotency, generating Wnt3a-conditioned medium, RT–PCR,
immunocytochemistry, L-DOPA reaction assay, immunohistochemis-
try, the Fontana–Masson stain, generation of 3D cultured skin in vitro,
and skin transplantation are described in Supplementary Materials
Online.
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